Chang Suwen
Department of Gynaecology, Yuhuangding Hospital, Yantai, Shangdong, China.
Cytojournal. 2025 May 14;22:54. doi: 10.25259/Cytojournal_31_2025. eCollection 2025.
Endometrial cancer (EC) ranks among the most prevalent malignant tumors affecting women, with metastasis and dissemination as the major contributors to poor prognosis. This study explores the involvement of forkhead box protein P2 (FOXP2) in EC cell invasion and migration, which is mediated through the activation of myosin light-chain kinase (MYLK).
Bioinformatic analysis was conducted to determine whether FOXP2 is expressed in EC. FOXP2 overexpression was achieved using a FOXP2 overexpression vector (oeFOXP2), and negative control (NC) was used for cell transfection. Cell counting kit-8, 5-ethynyl-2'-deoxyuridine, enzyme-linked immunosorbent assay, colony formation, wound healing, and Transwell assay were used to assess the capabilities of cell viability, invasion, migration, and proliferation. Western blot and quantitative real-time polymerase chain reaction (qRTPCR) analysis were used to measure the expression levels of proteins linked to the epithelial-mesenchymal transition. The correlation between FOXP2 and MYLK was analyzed using bioinformatics and validated by Western blot and qRT-PCR analysis. The MYLK-specific inhibitor ML-7 was employed to study the impact of MYLK-mediated FOXP2 on regulating the malignant biological processes of EC.
The oeFOXP2 group of EC cells exhibited a significant decrease in cell viability, colony formation, migration rate, and metastatic cell count compared with the NC group ( < 0.05). FOXP2 overexpression markedly increased caspase-3, caspase-8, caspase-9 activity ( < 0.05). Significant changes were detected in the expression of epithelial-mesenchymal transition marker proteins, with vimentin and N-cadherin expression noticeably declining and E-cadherin expression sharply rising ( < 0.05). The addition of the MYLK-specific inhibitor ML-7 reversed the effect of FOXP2 overexpression on the invasion and migration of EC cells.
FOXP2 suppresses the proliferation, invasion, and migration of EC cells through the activation of MYLK.
子宫内膜癌(EC)是影响女性的最常见恶性肿瘤之一,转移和扩散是导致预后不良的主要因素。本研究探讨叉头框蛋白P2(FOXP2)通过肌球蛋白轻链激酶(MYLK)的激活介导参与EC细胞侵袭和迁移的情况。
进行生物信息学分析以确定FOXP2在EC中是否表达。使用FOXP2过表达载体(oeFOXP2)实现FOXP2过表达,并使用阴性对照(NC)进行细胞转染。采用细胞计数试剂盒-8、5-乙炔基-2'-脱氧尿苷、酶联免疫吸附测定、集落形成、伤口愈合和Transwell测定来评估细胞活力、侵袭、迁移和增殖能力。采用蛋白质印迹法和定量实时聚合酶链反应(qRTPCR)分析来测量与上皮-间质转化相关的蛋白质表达水平。使用生物信息学分析FOXP2与MYLK之间的相关性,并通过蛋白质印迹法和qRT-PCR分析进行验证。采用MYLK特异性抑制剂ML-7研究MYLK介导的FOXP2对调节EC恶性生物学过程的影响。
与NC组相比,EC细胞的oeFOXP2组在细胞活力、集落形成、迁移率和转移细胞计数方面显著降低(<0.05)。FOXP2过表达显著增加了半胱天冬酶-3、半胱天冬酶-8、半胱天冬酶-9的活性(<0.05)。上皮-间质转化标志物蛋白的表达检测到显著变化,波形蛋白和N-钙黏蛋白表达明显下降,E-钙黏蛋白表达急剧上升(<0.05)。添加MYLK特异性抑制剂ML-7可逆转FOXP2过表达对EC细胞侵袭和迁移的影响。
FOXP2通过激活MYLK抑制EC细胞的增殖、侵袭和迁移。